Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral CenterIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), 2025, in press
-
A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like PhenotypeIn: Thyroid, Jg. 31, 2021, Nr. 2, S. 327 – 329
-
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma : Lessons From Individual Cases With Long-Term Follow-UpIn: Frontiers in Endocrinology, Jg. 12, 2021, 718418DOI, Online Volltext (Open Access)
-
Anaplastic thyroid carcinoma : review of treatment protocolsIn: Endocrine-Related Cancer, Jg. 25, 2018, Nr. 3, S. R153 – R161DOI (Open Access)
-
Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidismIn: European Journal of Endocrinology (EJE), Jg. 177, 2017, Nr. 3, S. 243 – 250
-
NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinomaIn: OncoTarget, Jg. 8, 2017, Nr. 26, S. 42613 – 42620DOI (Open Access)
-
Calcitonin-Screening und StimulationstestsIn: Der Nuklearmediziner, Jg. 39, 2016, Nr. 02, S. 111 – 119
-
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma : results of a multicenter study in GermanyIn: European Journal of Endocrinology (EJE), Jg. 175, 2016, Nr. 6, S. 521 – 529DOI (Open Access)
-
Perspectives for immunotherapy in endocrine cancerIn: Endocrine-Related Cancer, Jg. 23, 2016, Nr. 10, S. R469 – 84
-
Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patientsIn: European Journal of Endocrinology (EJE), Jg. 175, 2016, Nr. 3, S. 173 – 180DOI (Open Access)
-
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancerIn: Endocrine, Jg. 54, 2016, Nr. 3, S. 733 – 741
-
Molekularpathogenese von SchilddrüsentumorenIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 140, 2015, Nr. 8, S. 578 – 582
-
Aggressive treatment of a 51 year old patient with anaplastic thyroid cancer with over one year survivalIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 122, 2014, Nr. 3, S. P025
-
Management des fortgeschrittenen medullären Schilddrüsenkarzinoms : Therapie mit TyrosinkinaseinhibitorenIn: Der Onkologe, Jg. 20, 2014, Nr. 6, S. 591 – 598
-
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosisIn: Multiple Sclerosis Journal, Jg. 19, 2013, Nr. 12, S. 1676 – 1678
-
Diabetes insipidus as a rare cause of cognitive impairment in multiple sclerosisIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. P43
-
Diagnostik und Therapie der immunvermittelten Thyreoiditis unter Therapie mit Ipilimumab und NivolumabIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 15, 2017, Nr. Suppl. 3, S. 26 – 27
-
MCT 8 and LAT 2 expression in differentially functioning benign and malignant thyroid tumors
57th Symposium of the German Society of Endocrinology (DGE), 19th–22th March, 2014, Dresden, Germany,In: Experimental and Clinical Endocrinology & Diabetes. Stuttgart: Thieme, Jg. 122, 2014, Nr. 3, P082